Do analysts prefer BYRN or QUCY?

Byrna Technologies presently has a consensus target price of $7.88, indicating a potential upside of 132.30%. Given Byrna Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Byrna Technologies is more favorable than Mainz Biomed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Byrna Technologies 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.67 Mainz Biomed 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25

Does the media prefer BYRN or QUCY?

In the previous week, Byrna Technologies and Byrna Technologies both had 1 articles in the media. Byrna Technologies' average media sentiment score of 0.62 equaled Mainz Biomed'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Byrna Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mainz Biomed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer OPXS or QUCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Optex Systems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 3.00 Mainz Biomed 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25

Which has stronger earnings & valuation, OPXS or QUCY?

Optex Systems has higher revenue and earnings than Mainz Biomed. Mainz Biomed is trading at a lower price-to-earnings ratio than Optex Systems, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Optex Systems $41.34M 1.72 $5.15M $0.55 18.58 Mainz Biomed $540K 40.18 -$16.21M -$10.37 N/A

Does the media prefer OPXS or QUCY?

In the previous week, Optex Systems and Optex Systems both had 1 articles in the media. Mainz Biomed's average media sentiment score of 0.62 beat Optex Systems' score of 0.47 indicating that Mainz Biomed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Optex Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mainz Biomed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer QUCY or MOB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25 Mobilicom 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings & valuation, QUCY or MOB?

Mainz Biomed has higher earnings, but lower revenue than Mobilicom. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mainz Biomed $540K 40.18 -$16.21M -$10.37 N/A Mobilicom $3.36M 19.33 -$23.73M N/A N/A

Is QUCY or MOB more profitable?

Company Net Margins Return on Equity Return on Assets Mainz Biomed N/A N/A N/A Mobilicom N/A N/A N/A

Do analysts recommend QUCY or TPCS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25 Techprecision 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor QUCY or TPCS?

In the previous week, Techprecision had 3 more articles in the media than Mainz Biomed. MarketBeat recorded 4 mentions for Techprecision and 1 mentions for Mainz Biomed. Techprecision's average media sentiment score of 0.68 beat Mainz Biomed's score of 0.62 indicating that Techprecision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mainz Biomed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Techprecision 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend QUCY or XTIA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainz Biomed 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.25 XTI Aerospace 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media favor QUCY or XTIA?

In the previous week, XTI Aerospace had 24 more articles in the media than Mainz Biomed. MarketBeat recorded 25 mentions for XTI Aerospace and 1 mentions for Mainz Biomed. Mainz Biomed's average media sentiment score of 0.62 beat XTI Aerospace's score of -0.16 indicating that Mainz Biomed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mainz Biomed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive XTI Aerospace 0 Very Positive mention(s) 0 Positive mention(s) 19 Neutral mention(s) 3 Negative mention(s) 3 Very Negative mention(s) Neutral

Mainz Biomed (QUCY) Competitors

$1.48 -0.09 (-5.73%)

Closing price 09/1/2026 04:00 PM Eastern

Extended Trading

$1.49 +0.01 (+0.68%)

As of 06:28 AM Eastern

Compare

QUCY vs. BYRN, OPXS, MOB, TPCS, and XTIA

Should you buy Mainz Biomed stock or one of its competitors? Mainz Biomed's main competitors and comparable companies include Byrna Technologies (BYRN), Optex Systems (OPXS), Mobilicom (MOB), Techprecision (TPCS), and XTI Aerospace (XTIA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "aerospace & defense" industry.

How does Mainz Biomed compare to Byrna Technologies?

Byrna Technologies (NASDAQ:BYRN) and Mainz Biomed (NASDAQ:QUCY) are both small-cap industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.

Byrna Technologies has higher revenue and earnings than Mainz Biomed. Byrna Technologies is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Byrna Technologies	$118.12M	0.65	$9.69M	-$0.18	N/A
Mainz Biomed	$540K	40.18	-$16.21M	-$10.37	N/A

Byrna Technologies has a beta of 1.77, meaning that its stock price is 77% more volatile than the broader market. Comparatively, Mainz Biomed has a beta of 2.35, meaning that its stock price is 135% more volatile than the broader market.

In the previous week, Byrna Technologies and Byrna Technologies both had 1 articles in the media. Byrna Technologies' average media sentiment score of 0.62 equaled Mainz Biomed'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Byrna Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mainz Biomed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

25.5% of Byrna Technologies shares are owned by institutional investors. 9.8% of Byrna Technologies shares are owned by insiders. Comparatively, 3.1% of Mainz Biomed shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Mainz Biomed has a net margin of 0.00% compared to Byrna Technologies' net margin of -3.39%. Mainz Biomed's return on equity of 0.00% beat Byrna Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Byrna Technologies	-3.39%	-5.85%	-4.74%
Mainz Biomed	N/A	N/A	N/A

Byrna Technologies presently has a consensus target price of $7.88, indicating a potential upside of 132.30%. Given Byrna Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Byrna Technologies is more favorable than Mainz Biomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Byrna Technologies	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.67
Mainz Biomed	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25

Summary

Byrna Technologies beats Mainz Biomed on 9 of the 15 factors compared between the two stocks.

How does Mainz Biomed compare to Optex Systems?

Optex Systems (NASDAQ:OPXS) and Mainz Biomed (NASDAQ:QUCY) are both small-cap industrials companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

In the previous week, Optex Systems and Optex Systems both had 1 articles in the media. Mainz Biomed's average media sentiment score of 0.62 beat Optex Systems' score of 0.47 indicating that Mainz Biomed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Optex Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mainz Biomed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Optex Systems has a net margin of 9.77% compared to Mainz Biomed's net margin of 0.00%. Optex Systems' return on equity of 17.57% beat Mainz Biomed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Optex Systems	9.77%	17.57%	14.65%
Mainz Biomed	N/A	N/A	N/A

Optex Systems has a beta of 0.48, meaning that its share price is 52% less volatile than the broader market. Comparatively, Mainz Biomed has a beta of 2.35, meaning that its share price is 135% more volatile than the broader market.

Optex Systems has higher revenue and earnings than Mainz Biomed. Mainz Biomed is trading at a lower price-to-earnings ratio than Optex Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Optex Systems	$41.34M	1.72	$5.15M	$0.55	18.58
Mainz Biomed	$540K	40.18	-$16.21M	-$10.37	N/A

19.1% of Optex Systems shares are held by institutional investors. 27.7% of Optex Systems shares are held by company insiders. Comparatively, 3.1% of Mainz Biomed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Optex Systems	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	3.00
Mainz Biomed	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25

Summary

Optex Systems beats Mainz Biomed on 10 of the 13 factors compared between the two stocks.

How does Mainz Biomed compare to Mobilicom?

Mainz Biomed (NASDAQ:QUCY) and Mobilicom (NASDAQ:MOB) are both small-cap industrials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

Mainz Biomed has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market. Comparatively, Mobilicom has a beta of 2.26, suggesting that its stock price is 126% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
Mobilicom	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Mainz Biomed has higher earnings, but lower revenue than Mobilicom.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$540K	40.18	-$16.21M	-$10.37	N/A
Mobilicom	$3.36M	19.33	-$23.73M	N/A	N/A

In the previous week, Mainz Biomed had 1 more articles in the media than Mobilicom. MarketBeat recorded 1 mentions for Mainz Biomed and 0 mentions for Mobilicom. Mobilicom's average media sentiment score of 1.89 beat Mainz Biomed's score of 0.62 indicating that Mobilicom is being referred to more favorably in the news media.

Company	Overall Sentiment
Mainz Biomed	Positive
Mobilicom	Very Positive

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
Mobilicom	N/A	N/A	N/A

13.6% of Mobilicom shares are held by institutional investors. 3.1% of Mainz Biomed shares are held by insiders. Comparatively, 7.2% of Mobilicom shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Mainz Biomed beats Mobilicom on 6 of the 11 factors compared between the two stocks.

How does Mainz Biomed compare to Techprecision?

Mainz Biomed (NASDAQ:QUCY) and Techprecision (NASDAQ:TPCS) are both small-cap industrials companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

Techprecision has higher revenue and earnings than Mainz Biomed. Techprecision is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$540K	40.18	-$16.21M	-$10.37	N/A
Techprecision	$31.64M	1.72	-$1.66M	-$0.13	N/A

In the previous week, Techprecision had 3 more articles in the media than Mainz Biomed. MarketBeat recorded 4 mentions for Techprecision and 1 mentions for Mainz Biomed. Techprecision's average media sentiment score of 0.68 beat Mainz Biomed's score of 0.62 indicating that Techprecision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mainz Biomed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Techprecision	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mainz Biomed has a net margin of 0.00% compared to Techprecision's net margin of -3.66%. Mainz Biomed's return on equity of 0.00% beat Techprecision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
Techprecision	-3.66%	-15.07%	-3.75%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
Techprecision	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

15.5% of Techprecision shares are owned by institutional investors. 3.1% of Mainz Biomed shares are owned by insiders. Comparatively, 15.3% of Techprecision shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Mainz Biomed has a beta of 2.35, meaning that its share price is 135% more volatile than the broader market. Comparatively, Techprecision has a beta of 0.41, meaning that its share price is 59% less volatile than the broader market.

Summary

Mainz Biomed beats Techprecision on 8 of the 15 factors compared between the two stocks.

How does Mainz Biomed compare to XTI Aerospace?

Mainz Biomed (NASDAQ:QUCY) and XTI Aerospace (NASDAQ:XTIA) are both small-cap industrials companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mainz Biomed	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.25
XTI Aerospace	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, XTI Aerospace had 24 more articles in the media than Mainz Biomed. MarketBeat recorded 25 mentions for XTI Aerospace and 1 mentions for Mainz Biomed. Mainz Biomed's average media sentiment score of 0.62 beat XTI Aerospace's score of -0.16 indicating that Mainz Biomed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mainz Biomed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
XTI Aerospace	0 Very Positive mention(s)	0 Positive mention(s)	19 Neutral mention(s)	3 Negative mention(s)	3 Very Negative mention(s)	Neutral

Mainz Biomed has higher earnings, but lower revenue than XTI Aerospace. XTI Aerospace is trading at a lower price-to-earnings ratio than Mainz Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mainz Biomed	$540K	40.18	-$16.21M	-$10.37	N/A
XTI Aerospace	$22.49M	1.97	-$68.76M	-$5.20	N/A

Mainz Biomed has a net margin of 0.00% compared to XTI Aerospace's net margin of -171.13%. Mainz Biomed's return on equity of 0.00% beat XTI Aerospace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mainz Biomed	N/A	N/A	N/A
XTI Aerospace	-171.13%	-2,044.78%	-105.02%

11.7% of XTI Aerospace shares are held by institutional investors. 3.1% of Mainz Biomed shares are held by insiders. Comparatively, 7.4% of XTI Aerospace shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Mainz Biomed has a beta of 2.35, meaning that its stock price is 135% more volatile than the broader market. Comparatively, XTI Aerospace has a beta of 4.79, meaning that its stock price is 379% more volatile than the broader market.

Summary

Mainz Biomed and XTI Aerospace tied by winning 7 of the 14 factors compared between the two stocks.

Get Mainz Biomed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QUCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QUCY vs. The Competition

Export

Metric	Mainz Biomed	Aerospace & Defense Industry	Industrials Sector	NASDAQ Exchange
Market Cap	$23.02M	$21.34B	$10.47B	$12.83B
Dividend Yield	N/A	1.66%	97.25%	11.78%
P/E Ratio	-0.14	38.53	25.96	24.97
Price / Sales	40.18	141.95	375.92	93.29
Price / Cash	N/A	27.66	24.08	52.85
Price / Book	1.07	6.00	4.53	6.03
Net Income	-$16.21M	$562.41M	$611.46M	$348.89M
7 Day Performance	7.64%	-4.65%	-2.34%	-2.29%
1 Month Performance	29.82%	-1.31%	0.22%	2.94%
1 Year Performance	N/A	9.11%	8.33%	14.08%

Mainz Biomed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QUCY Mainz Biomed	0.8853 of 5 stars	$1.48 -5.7%	N/A	N/A	$23.02M	$540K	N/A	30
BYRN Byrna Technologies	3.9931 of 5 stars	$3.59 -0.3%	$7.88 +119.4%	-83.4%	$81.46M	$118.12M	N/A	150
OPXS Optex Systems	2.0155 of 5 stars	$10.06 -1.8%	N/A	-7.0%	$70.02M	$41.34M	18.29	80	News Coverage
MOB Mobilicom	1.0137 of 5 stars	$5.54 -3.3%	$2,750.00 +49,539.0%	-99.7%	$67.67M	$3.64M	N/A	24	Positive News Gap Down
TPCS Techprecision	0.4787 of 5 stars	$5.68 +2.3%	N/A	-0.9%	$57.37M	$33.36M	N/A	160	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QUCY) was last updated on 9/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mainz Biomed (QUCY) Competitors

QUCY vs. BYRN, OPXS, MOB, TPCS, and XTIA

How does Mainz Biomed compare to Byrna Technologies?

Summary

How does Mainz Biomed compare to Optex Systems?

Summary

How does Mainz Biomed compare to Mobilicom?

Summary

How does Mainz Biomed compare to Techprecision?

Summary

How does Mainz Biomed compare to XTI Aerospace?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QUCY vs. The Competition

Mainz Biomed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mainz Biomed (QUCY) Competitors

QUCY vs. BYRN, OPXS, MOB, TPCS, and XTIA

How does Mainz Biomed compare to Byrna Technologies?

Which has preferable valuation and earnings, BYRN or QUCY?

Which has more volatility and risk, BYRN or QUCY?

Does the media prefer BYRN or QUCY?

Do institutionals & insiders believe in BYRN or QUCY?

Is BYRN or QUCY more profitable?

Do analysts prefer BYRN or QUCY?

Summary

How does Mainz Biomed compare to Optex Systems?

Does the media prefer OPXS or QUCY?

Is OPXS or QUCY more profitable?

Which has more risk & volatility, OPXS or QUCY?

Which has stronger earnings & valuation, OPXS or QUCY?

Do institutionals and insiders believe in OPXS or QUCY?

Do analysts prefer OPXS or QUCY?

Summary

How does Mainz Biomed compare to Mobilicom?

Which has more risk and volatility, QUCY or MOB?

Do analysts prefer QUCY or MOB?

Which has preferable earnings & valuation, QUCY or MOB?

Does the media refer more to QUCY or MOB?

Is QUCY or MOB more profitable?

Do institutionals & insiders hold more shares of QUCY or MOB?

Summary

How does Mainz Biomed compare to Techprecision?

Which has preferable valuation & earnings, QUCY or TPCS?

Does the media favor QUCY or TPCS?

Is QUCY or TPCS more profitable?

Do analysts recommend QUCY or TPCS?

Do insiders & institutionals believe in QUCY or TPCS?

Which has more volatility & risk, QUCY or TPCS?

Summary

How does Mainz Biomed compare to XTI Aerospace?

Do analysts recommend QUCY or XTIA?

Does the media favor QUCY or XTIA?

Which has better earnings & valuation, QUCY or XTIA?

Is QUCY or XTIA more profitable?

Do insiders and institutionals hold more shares of QUCY or XTIA?

Which has more volatility and risk, QUCY or XTIA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QUCY vs. The Competition

Mainz Biomed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools